|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 345.80 USD | -0.02% |
|
+2.02% | +2.83% |
| 13/01 | Baird Adjusts Cencora Price Target to $415 From $392, Maintains Outperform Rating | MT |
| 12/01 | Cencora, Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 09:00 AM |
| Capitalization | 6.71TCr 5.77TCr 5.38TCr 5TCr 9.32TCr 6,06000Cr 10TCr 62TCr 24TCr 2,89600Cr 25TCr 25TCr 10,68000Cr | P/E ratio 2026 * |
24.3x | P/E ratio 2027 * | 21.2x |
|---|---|---|---|---|---|
| Enterprise value | 6.83TCr 5.87TCr 5.47TCr 5.08TCr 9.49TCr 6,16700Cr 10TCr 63TCr 25TCr 2,94700Cr 26TCr 25TCr 10,86900Cr | EV / Sales 2026 * |
0.2x | EV / Sales 2027 * | 0.18x |
| Free-Float |
35.16% | Yield 2026 * |
0.66% | Yield 2027 * | 0.69% |
Last Transcript: Cencora, Inc.
| 1 day | -0.20% | ||
| 1 week | +2.02% | ||
| Current month | +2.83% | ||
| 1 month | -0.86% | ||
| 3 months | +9.24% | ||
| 6 months | +16.91% | ||
| Current year | +2.83% |
| 1 week | 333.79 |  | 349.02 |
| 1 month | 329.1 | | 351.99 |
| Current year | 329.1 | | 349.55 |
| 1 year | 236.37 | | 377.54 |
| 3 years | 147.48 | | 377.54 |
| 5 years | 100.71 | | 377.54 |
| 10 years | 68.38 | | 377.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Mauch
CEO | Chief Executive Officer | 59 | 01/10/2024 |
James Cleary
DFI | Director of Finance/CFO | 63 | 09/11/2018 |
Pawan Verma
CTO | Chief Tech/Sci/R&D Officer | 50 | 04/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Lon Greenberg
BRD | Director/Board Member | 75 | 16/05/2013 |
Robert Mauch
BRD | Director/Board Member | 59 | 01/10/2024 |
D. Mark Durcan
CHM | Chairman | 64 | 01/10/2025 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.05% | +2.02% | +44.68% | +111.56% | 6.71TCr | |
| -0.74% | -2.79% | +9.27% | +8.91% | 22TCr | |
| -0.19% | -3.41% | +13.04% | +19.94% | 12TCr | |
| +0.39% | -0.22% | -14.22% | -20.99% | 5.74TCr | |
| +4.93% | +7.07% | +27.36% | +96.63% | 5.26TCr | |
| -0.92% | +3.64% | - | - | 3.57TCr | |
| +1.17% | +0.75% | -10.79% | -35.51% | 2.74TCr | |
| -0.62% | -1.04% | +23.58% | +28.33% | 2.55TCr | |
| -0.14% | -3.86% | +6.14% | -33.64% | 2.43TCr | |
| +0.35% | +0.02% | -23.86% | +27.94% | 2.1TCr | |
| Average | +0.38% | -0.15% | +8.35% | +22.58% | 6.51TCr | |
| Weighted average by Cap. | +0.06% | -1.32% | +11.69% | +24.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 34TCr 29TCr 27TCr 25TCr 47TCr 30,76300Cr 51TCr 3,13800Cr 1,23300Cr 14,70100Cr 1,27700Cr 1,25100Cr 54,21900Cr | 36TCr 31TCr 29TCr 27TCr 50TCr 32,76400Cr 54TCr 3,34200Cr 1,31300Cr 15,65700Cr 1,36100Cr 1,33300Cr 57,74600Cr |
| Net income | 238.9Cr 205.29Cr 191.44Cr 177.88Cr 331.91Cr 22TCr 357.9Cr 2.2TCr 864.75Cr 10TCr 895.92Cr 877.55Cr 38TCr | 312.45Cr 268.49Cr 250.37Cr 232.65Cr 434.09Cr 28TCr 468.08Cr 2.88TCr 1.13TCr 13TCr 1.17TCr 1.15TCr 50TCr |
| Net Debt | 118.84Cr 102.12Cr 95Cr 88Cr 165.1Cr 11TCr 178.03Cr 1.09TCr 430.15Cr 5.13TCr 445.66Cr 436.52Cr 19TCr | -109.99Cr -95Cr -88Cr -82Cr -152.81Cr -9.93TCr -164.77Cr -1.01TCr -398.12Cr -4.75TCr -412.48Cr -404.02Cr -18TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/26/14 | 347.30 $ | +0.41% | 46,886 |
| 13/26/13 | 345.88 $ | +1.09% | 11,63,056 |
| 12/26/12 | 342.16 $ | +1.93% | 10,13,173 |
| 09/26/09 | 335.69 $ | -0.01% | 9,16,997 |
| 08/26/08 | 335.74 $ | -1.37% | 11,33,960 |
Delayed Quote Nyse, January 14, 2026 at 08:09 pm IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- COR Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition